Neutropenia and Agranulocytosis in Patients Receiving Clozapine in the UK and Ireland

Abstract

The use of a patient monitoring service kept the haematological risks associated with using clozapine within acceptable limits, particularly in view of the benefits of this medication in treatment-resistant schizophrenia.